8-K
Current Report
Axsome Therapeutics, Inc. Filed Acc 0001104659-17-071533
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading a17-27901_18k.htm…